These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9199438)

  • 1. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
    Peterson EM; Cheng X; Motin VL; de la Maza LM
    Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis.
    Peterson EM; Cheng X; Pal S; de la Maza LM
    Infect Immun; 1993 Feb; 61(2):498-503. PubMed ID: 8423079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H; Parnell M; Caldwell HD
    Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Pal S; Bravo J; Peterson EM; de la Maza LM
    Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
    Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
    Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.
    Qu Z; Cheng X; de la Maza LM; Peterson EM
    Infect Immun; 1993 Apr; 61(4):1365-70. PubMed ID: 7681045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
    Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae.
    Peterson EM; de la Maza LM; Brade L; Brade H
    Infect Immun; 1998 Aug; 66(8):3848-55. PubMed ID: 9673271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin.
    Su H; Watkins NG; Zhang YX; Caldwell HD
    Infect Immun; 1990 Apr; 58(4):1017-25. PubMed ID: 2318528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies.
    Peterson EM; Cheng X; Markoff BA; Fielder TJ; de la Maza LM
    Infect Immun; 1991 Nov; 59(11):4147-53. PubMed ID: 1718870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.
    Brossay L; Villeneuve A; Paradis G; Coté L; Mourad W; Hébert J
    Infect Immun; 1994 Feb; 62(2):341-7. PubMed ID: 7507888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
    Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
    Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of neutralization of Chlamydia trachomatis infection by high avidity monoclonal antibodies to surface-exposed major outer membrane protein variable domain IV.
    Degn LLT; Bech D; Christiansen G; Birkelund S
    Mol Immunol; 2023 Nov; 163():163-173. PubMed ID: 37801817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response.
    Kaushic C; Murdin AD; Underdown BJ; Wira CR
    Infect Immun; 1998 Mar; 66(3):893-8. PubMed ID: 9488372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
    Pal S; Davis HL; Peterson EM; de la Maza LM
    Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.